157 related articles for article (PubMed ID: 22123574)
1. [Inappropriately undetectable thyroglobulin after exclusion of interference from thyroglobulin antibodies].
Munier P; Courtier F; Barrial K; Chikh K; Claustrat F; Le Bricon T; Bronner J; Sanabria E
Ann Biol Clin (Paris); 2011; 69(6):721-5. PubMed ID: 22123574
[TBL] [Abstract][Full Text] [Related]
2. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
[TBL] [Abstract][Full Text] [Related]
5. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.
Ferrari L; Seregni E; Aliberti G; Martinetti A; Pallotti F; Villano C; Lucignani G; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):237-42. PubMed ID: 15499298
[TBL] [Abstract][Full Text] [Related]
7. Concordance between thyroglobulin antibody assays.
Taylor KP; Parkington D; Bradbury S; Simpson HL; Jefferies SJ; Halsall DJ
Ann Clin Biochem; 2011 Jul; 48(Pt 4):367-9. PubMed ID: 21502198
[TBL] [Abstract][Full Text] [Related]
8. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
9. Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Tozzoli R; Caputo M; Ceriani L; Verburg FA
Head Neck; 2012 Oct; 34(10):1369-71. PubMed ID: 22083639
[TBL] [Abstract][Full Text] [Related]
10. Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457).
Lee JI; Kim JY; Choi JY; Kim HK; Jang HW; Hur KY; Kim JH; Kim KW; Chung JH; Kim SW
Head Neck; 2010 Sep; 32(9):1161-6. PubMed ID: 20029980
[TBL] [Abstract][Full Text] [Related]
11. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
[TBL] [Abstract][Full Text] [Related]
12. Do thyroid cancer patients with basal undetectable Tg measured by current immunoassays require rhTSH testing?
Díaz-Soto G; Puig-Domingo M; Martínez-Pino I; Martínez de Osaba MJ; Mora M; Rivera-Fillat F; Halperin I
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):348-52. PubMed ID: 21264807
[TBL] [Abstract][Full Text] [Related]
13. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.
Schlumberger M; Fragu P; Gardet P; Lumbroso J; Violot D; Parmentier C
Eur J Nucl Med; 1991; 18(3):153-7. PubMed ID: 2040337
[TBL] [Abstract][Full Text] [Related]
14. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas].
Tang GS; Xu J; Yu Y; Pan MZ; Wang JR; Yuan LP; Jiang T; Huang F; Jing CL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559
[TBL] [Abstract][Full Text] [Related]
15. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
16. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies.
Marquet PY; Daver A; Sapin R; Bridgi B; Muratet JP; Hartmann DJ; Paolucci F; Pau B
Clin Chem; 1996 Feb; 42(2):258-62. PubMed ID: 8595721
[TBL] [Abstract][Full Text] [Related]
18. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
[TBL] [Abstract][Full Text] [Related]
19. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
Spencer CA; Wang CC
Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
[TBL] [Abstract][Full Text] [Related]
20. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
